04/29/2025
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025
7:16 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/07/2025
5:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025
8:33 AM | Evaxion Biotech A/S (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/01/2025
6:45 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025
3:45 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/24/2025
11:15 PM | Evaxion Biotech A/S (Filer)
| Form EFFECT | |
03/04/2025
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for EVAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2025
4:44 PM | ARMISTICE CAPITAL, LLC (Filed by)
Evaxion Biotech A/S (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2025
7:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
3:15 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
5:33 AM | Evaxion Biotech A/S (Filer)
| Form 424B4 | |
01/30/2025
7:05 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2025
11:15 PM | Evaxion Biotech A/S (Filer)
| Form EFFECT | |
01/28/2025
3:34 PM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
01/28/2025
7:26 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025
7:25 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025
5:16 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2025
7:10 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
3:15 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2025
8:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024
4:09 PM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
12/17/2024
7:16 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024
7:10 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024
8:01 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
3:53 PM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
12/03/2024
5:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
8:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
6:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
6:04 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2024
3:09 PM | Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
| Form SC 13G/A | |
10/31/2024
9:20 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
8:10 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The next market Nvidia is positioned to dominate … (Ad) Robots — built by Nvidia.
Forbes says this could be " a $24 trillion opportunity for investors."
Huang said, "The ChatGPT moment for robotics is right around the corner."
In fact, I believe these robots could impact 65 million Americans lives — this year.
And one stock — currently priced around $7 — could be the biggest winner. To see a live demonstration with one of these robots, simply click here. |
10/09/2024
10:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024
6:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024
6:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024
7:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
7:22 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
7:24 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 424B4 | |
08/22/2024
11:15 PM | Evaxion Biotech A/S (Filer)
| Form EFFECT | |
08/20/2024
7:45 AM | Evaxion Biotech A/S (Filer)
| Form F-1/A | |
08/19/2024
4:31 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:15 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
6:45 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2024
7:32 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024
7:00 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024
3:31 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
3:50 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024
3:30 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
8:13 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
8:25 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
7:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
8:30 AM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
4:05 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024
4:29 PM | Evaxion Biotech A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy EVAX Stock Free EVAX Stock Alerts